Search
for
Sort by
Research 30 of 455
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Infliximab as First‐Line Therapy in Severe Pediatric Crohn Disease
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- Alopecia areata in a patient receiving infliximab
- Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome
- Infliximab-Associated Psoriasiform Alopecia
- Infliximab Induced Lupus in Crohnʼs Disease
- S4890 Infliximab-Induced Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis Syndrome
- Successful treatment of refractory alopecia universalis with infliximab: First case report in Sri Lanka
- Dissecting cellulitis of the scalp successfully treated with infliximab
- Local infusion of infliximab for the treatment of acute joint inflammation
- Baseline methotrexate does not impact the incidence of infliximab infusion reactions: Results from a Canadian real-world treatment registry
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
- Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Safety of dermatologic medications in pregnancy and lactation
- Interventions for nail psoriasis
- Drugs and Hair Loss
- An Update on Medical Treatment Options for Hidradenitis Suppurativa
- Hidradenitis Suppurativa
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- Tumor necrosis factor-induced alopecia: alternative pathology and therapy
- Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept
- TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- S3909 Paradoxical Psoriasis and Alopecia Areata After the Use of Anti-TNF in a Patient With Crohn's Cisease
- Current systemic treatment strategies for hidradenitis suppurativa